Etiopathogenesis of Hodgkin lymphoma;Etiopatogeneza chłoniaka Hodgkina

Acta Haematologica Polonica

Volumn 34, Issue 3, 2003, Pages 277-286

  Juszczyński, Przemysław ^a   Czyz, Jarosław ^b   Kalinka, Ewa ^c   Warzocha, Krzysztof ^d  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Klinika Hematologii   (Poland)

^c Ośrodka Onkologicznego ^*  (Poland)

^d INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

Etiopathogenesis; Hodgkin's lymphoma

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

CARCINOGENESIS; CELL TRANSFORMATION; GENE OVEREXPRESSION; HEMATOPOIETIC SYSTEM; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LYMPHOPROLIFERATIVE DISEASE; PROGNOSIS; PROTEIN FUNCTION; REED STERNBERG CELL; REVIEW; VIRUS CARCINOGENESIS; VIRUS INFECTION;

EID: 0346730011     PISSN: 00015814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Stein H, Hummel M. Cellular origin and clonality of classic Hodgkin's lymphoma: immunophenotypic and molecular studies. Semin Hematol 1999; 36: 233-241.
2. Foss HD, Anagnostopoulos I, Araujo I i wsp. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996; 88: 4005-4011.
3. Carbone A, Gloghini A, Gattei V i wsp. Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1. Blood 1997; 89: 3787-3794.
4. Pinkus GS, Pinkus JL, Langhoff E i wsp. Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin's disease. Evidence for a dendritic or B cell derivation? Am J Pathol 1997; 150: 543-562.
5. van den Berg A, Visser L, Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma. Am J Pathol 1999; 154: 1685-1691.
6. Kppers R, Rajewsky K. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annu Rev Immunol 1998; 16: 471-493.
7. Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines. Leuk Lymphoma 1993; 9: 1-25.
8. Kadin ME, Drews R, Samel A, Gilchrist A, Kocher O. Hodgkin's lymphoma of T-cell type: clonal association with a CD30+ cutaneous lymphoma. Hum Pathol 2001; 32: 1269-1272.
9. Kuppers R, Rajewsky K, Zhao M i wsp. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 1994; 91: 10962-10966.
10. Kanzler H, Hansmann ML, Kapp U i wsp. Molecular single cell analysis demonstrates the derivation of a peripheral blood derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient. Blood 1996; 87: 3429-3436.
11. Kanzler H, Kuppers R, Hansmann ML, Rajewsky K. Hodgkin and Reed Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184: 1495-1505.
12. Jox A, Zander T, Kuppers R i wsp. Somatic mutations within the untranslated regions of rearranged Ig genes in a case of classical Hodgkin's disease as a potential cause for the absence of Ig in the lymphoma cells. Blood 1999; 93: 3964-3972.
13. Re D, Muschen M, Ahmadi T i wsp. Oct-2 and Bob-1 deficiency in Hodgkin and Reed-Sternberg cells. Cancer Res 2001; 61: 2080-2084.
14. Stein H, Marafioti T, Foss HD i wsp. Down-regulation of BOB.1/OBF. 1 and Oct2 in classical Hodgkin's disease but not in lymphocyte predominant Hodgkin's disease correlates with immunoglobulin transcription. Blood 2001; 97: 496-501.
15. Torlakovic E, Tierens A, Dang HD i wsp. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. Am J Pathol 2001; 159: 1807-1814.
16. IARC. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17-24 June 1997. IARC Monogr Eval Carcinog Risks Hum 1997; 70: 1-492.
17. Engels N, Merchant M, Pappu R i wsp. Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module. J Exp Med 2001; 194: 255-264.
18. Gutensohn N, Cole P. Epidemiology of Hodgkin's disease. Semin Oncol 1980; 7: 92-102.
19. Hjalgrim H, Askling J, Sorensen P i wsp. Risk of Hodgkin's disease and other cancers after infectious mononucleosis. J Natl Cancer Inst 2000; 92: 1522-1528.
20. Jarrett RF, Gledhill S, Qureshi F i wsp. Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia 1988; 2: 496-502.
21. Secchiero P, Bonino LD, Lusso P i wsp. Human herpesvirus type 7 in Hodgkin's disease. Br J Haematol 1998; 101: 492-499.
22. Benharroch D, Shemer-Avni Y, Levy A i wsp. New candidate virus in association with Hodgkin's disease. Leuk Lymphoma 2003; 44: 605-610.
23. Mack TM, Cozen W, Shibata DK i wsp. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Eng J Med 1995; 332: 413-418.
24. Bargou RC, Leng CD. i wsp. High-level nuclear NFκB and Oct-2 is a common feature of cultured Hodgkin/Reed Sternberg cells. Blood 1996; 87: 4340-4347.
25. Bargou RC, Emmerich D, Krappman K. Constitutive nuclear factor κB- Rel-A activation is required for proliferation and survival of Hodgkin disease tumor cells. J Clin Invest 1997; 100: 2961-2969.
26. Zandi E, Rothwarf DM, Delhase M i wsp. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997; 91: 243-252.
27. Regnier CH, Song HY, Gao X i wsp. Identification and characterization of an IkappaB kinase. Cell 1997; 90: 373-383.
28. DiDonato JA, Hayakawa M, Rothwarf DM i wsp. A cytokine responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997; 386: 548-555.
29. Mercurio F, Zhu H, Murray BW i wsp. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 1997; 278: 860-866.
30. Jarrett RF, MacKenzie J. Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease. Semin Hematol 1999; 36: 260-269.
31. Emmerich F, Meiser M, Hummel M i wsp. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood 1999; 94: 3129-3134.
32. Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkBa. Oncogene 1999; 18: 3063-3070.
33. Jungnickel B, Staratschek-Jox A, Brduninger A i wsp. Clonal deleterious mutations in the IkBa gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 1999; 191: 395-402.
34. Joos S, Menz CK, Wrobel G i wsp. Classical Hodgkin lymphoma is characterized by recurrent copy number gainsof the short arm of chromosome 2. Blood 2002; 99: 1381-1387.
35. Satterwhite E, Sonoki T, Willis TG i wsp. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 2001; 98: 3413-3420.
36. Carbone A, Gloghini A, Gruss HJ, Pinto A. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 1995; 147: 912-922.
37. Messineo C, Jamerson MH, Hunter E i wsp. Gene expression by single Reed-Sternberg cells: pathways of apoptosis and activation. Blood 1998; 91: 2443-2451.
38. Gruss HJ, Ulrich D, Dower SK, Herrmann F, Brach MA. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor. Blood 1996; 87: 2443-2449.
39. Hinz M, Löser P, Mathas S, Krappmann D, Dörken B, Scheidereit C. Constitutive NFκB maintains high expresion of a characteristic gene network, including CD40 and CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 2001, 97: 2798-2807.
40. Montesinos-Rongen M, Roers A, Küppers R, Rajewsky K, Hansmann ML. Mutation of the p53 Gene Is Not a Typical Feature of Hodgkin and Reed-Sternberg Cells in Hodgkin's Disease. Blood 1999; 94: 1755-1760.
41. Dürkop H, Foss HD, Demel G, Klotzbach H, Hahn C, Stein H. Tumor necrosis factor receptor-associated factor 1 Is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells. Blood 1999; 93: 617-623.
42. Thomas RK, Kallenborn A, Wickenhauser C. Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells. Am J Pathol 2002; 160: 1521-1528.
43. Garcia JF, Camacho FI, Morente M i wsp. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood 2003; 101: 681-689.
44. Hinz M, Löser P, Mathas S. Constitutive NF-kB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 2001; 97: 2798-2807.
45. Hinz M, Lemke P, Löser P, i wsp. Nuclear factor B- dependent gene expression profiling of Hodgkin' sdisease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 2002; 196: 605-617.
46. Skinnider BF, Elis AJ, Gascoyne RD i wsp. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed Sternberg cells of Hodgkin lymphoma. Blood 2001; 97: 250-255.
47. Kapp U, Yeh WC, Patterson B i wsp. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med 1999; 189: 1939-1946.
48. Kim SH, Choi EY, Shin YK i wsp. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through down-regulation of CD99 (Mic2). Blood 1998; 92: 4287-4295.
49. Lee IS, Kim MK, Choi EY i wsp. CD99 expression is positively regulated by Sp1 and is negatively regulated by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kB. Blood 2001; 97: 3596-3604.
50. Teruya-Feldstein J, Tosato G, Jaffe ES. The role of chemokines in Hodgkin's disease. Leuk Lymph 2000; 38: 363-371.
51. Höpken UE, Foss HD, Meyer D i wsp. Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. Blood 2002; 99: 1109-1116.
52. Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood 2002; 99: 4283-4297.